Amylyx Pharmaceuticals Inc (AMLX) Stock: Tracking the Weekly Performance
The stock of Amylyx Pharmaceuticals Inc (AMLX) has seen a -5.88% decrease in the past week, with a -38.89% drop in the past month, and
The stock of Amylyx Pharmaceuticals Inc (AMLX) has seen a -5.88% decrease in the past week, with a -38.89% drop in the past month, and
In the past week, AMLX stock has gone down by -2.99%, with a monthly decline of -28.83% and a quarterly plunge of -86.65%. The volatility
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) has a price-to-earnings ratio that is above its average at 2.94x. The stock has a 36-month beta value of -0.81.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX)’s stock price has plunge by 2.67relation to previous closing price of 2.62. Nevertheless, the company has seen a -0.74% plunge
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) has a higher price-to-earnings ratio of 3.84x compared to its average ratio, The 36-month beta value for AMLX is at
As a result of a significant approval, Amylyx Pharmaceuticals Inc. (Nasdaq: AMLX) shares rose 9.34% in after-hours trading to $33.11. The stock rose 3.28% to
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.